BAY-8002 is a potent, selective, orally active inhibitor of monocarboxylate transporter 1 ( MCT1 ) , with an IC 50 of 85 nM in the MCT1-expressing DLD-1 cells, displays excellent selectivity against MCT4 . Anti-tumor activity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Monocarboxylate Transporter
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.